CR GROUP L.P. reported 2 transactions at T2 BIOSYSTEMS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/16/2024ACC: 0001415889-24-004167
+741.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
824.22K acquired · 82.42K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+335.95K
Price / share
—
Trade value
—
% of position
New position
2/14/2024
0.00→335.95K
Common Stock
Indirect
Shares
+488.27K
Price / share
—
Trade value
—
% of position
New position
2/14/2024
0.00→488.27K
Total
Net shares
+824.22K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/14/2024 | C · Conversion | +335.95K | — | — | New position | 0.00 | 335.95K |
| Common Stock Indirect | 2/14/2024 | C · Conversion | +488.27K | — | — | New position | 0.00 | 488.27K |
| Total | +824.22K | $0.00 | ||||||
Derivative Transactions2
Series B Preferred Stock
Indirect
Converts to
Common Stock
335.95K shares
Shares
−33.59K
Strike price
Held after
0.00
Exercisable
—
2/14/2024
Series B Preferred Stock
Indirect
Converts to
Common Stock
488.27K shares
Shares
−48.83K
Strike price
Held after
10.88K
Exercisable
—
2/14/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock335.95K shares | 2/14/2024 | C · Conversion | −33.59K | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock488.27K shares | 2/14/2024 | C · Conversion | −48.83K | — | 10.88K |